Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Policy, Guidelines, and Disparities Peter B. Bach, MD, MAPP Memorial Sloan-Kettering Cancer Center [email protected] Overview • The goal of practice guidelines is to: – Improve the quality of care? – Manage care? – Save money? – Monitor the quality of care? – Reduce disparities? – Give academics (with weird skills) something to do? Improve care quality • Underlying assumption: care is sub-standard • Practice guidelines used broadly would raise average level • Have to assume that deviations from guidelines net harmful – As opposed to important personalization • Clinical decision support can have a guidelines background Clinical decision support Manage care (oncology example) • Pathways tell doctors which treatments to use in common conditions • Mostly payer contracts linked to pathways ask for 80% adherence Save money through competition Save money: Guidelines for Metastatic NonSmall Cell Lung Cancer NCCN (2009) ACCP (2007) CCO (2009) Alberta (2009) Australian (2004) NICE (2009) Pemetrexed/Cisplatin X X X X - X Gemcitabine/Cisplatin X X X X X X Docetaxel/Cisplatin X X X X X X Irinotecan/Cisplatin X X X X X - Vinorelbine/Cisplatin X X X X X X Etoposide/Cisplatin X X X X X - Vinblastine/Cisplatin X X X X X - Paclitaxel/Cisplatin X X X X X X Metastatic Non-Small Cell Lung Cancer Name Total Chemotherapy Drug Cost Monthly Chemotherapy Drug Cost Total Cost (12 Weeks) Monthly Cost Pemetrexed/Cisplatin1-4,6 $16,913.37 $6,105.91 $19,594.13 $7,073.69 Gemcitabine/Cisplatin1-6 $9,745.83 $3,518.35 $13,303.24 $4,802.61 Docetaxel/Cisplatin1-6 $8,916.64 $3,219.00 $11,647.20 $4,204.77 Irinotecan/Cisplatin1-5 $934.60 $337.40 $7,984.63 $2,882.54 Vinorelbine/Cisplatin1-6 $519.45 $187.53 $4,929.03 $1,779.43 Etoposide/Cisplatin1-5 $217.06 $78.36 $4,453.86 $1,607.89 Vinblastine/Cisplatin1-5 $183.97 $66.41 $3,741.38 $1,350.68 Paclitaxel/Cisplatin1-6 $518.45 $187.17 $3,578.70 $1,291.95 1 National Comprehensive Cancer Center (NCCN), 2 American College of Chest Physicians, 3 Cancer Care Ontario (CCO), 4 Alberta Health Services, 5 Australian National Health and Medical Research Council, 6 National Institute for Health and Clinical Excellence (NICE) Using episode payment $8,000 $7,000 Cost per Month of Treatment $6,000 $5,000 Administration Fees and Supportive Care Costs Chemotherapy Cost Potential Loss for Physician $4,000 $3,000 $2,000 $1,000 $0 Potential Profit for Physician Metastatic Hormone Refractory Prostate Cancer Drug (does not include support or adminstration) Monthly Cost $ 37,668 Docetaxel (Generic) $ 772 Flutamide (Generic) $ 237 Bicalutamide (Casodex) $ 552 Bicalutamide (Generic) $ 43 Nilutamide (Nilandron) $ 749 Antiandrogen withdrawal $ - Ketoconazole $ 201 Arbiraterone acetate (Zytiga) $ 5,778 Anti-Androgens Sipuleucel-T (Provenge) Steroids negligible Diethylstilbestrol (or other estrogen) negligible Monitor the quality of care Reduce disparities Give academics work Summary of Published Guidelines on LDCT Screening for Lung Cancer Org. Type of NLST Like Others? Basis Statement Subjects? ACCP/ ASCO/ ATS Evidence based Suggest it be guideline offered No Systematic review, meta-analysis, grading of evidence ACS Interim guidance May be considered No Interim guidance pending full review ALA Guidance Recommended No Not specified (selective literature) NCCN Consensus guidelines Recommended Yes, for some individuals based on risk Not specified (selective literature) IASLC Statement Considered appropriate to discuss with physician No Not specified AATS Clinical guidelines Recommended Yes, for some individuals based on risk Not specified (selective literature) http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm280536.htm Then there’s the dissemination challenge Two Views of the Population Benefit Laurie Fenton Ambrose President and CEO Lung Cancer Alliance Straight Extrapolation from the NLST NLST Number screened Number of deaths prevented Number of years Number lung cancer deaths avoided/year 80,000 avoided deaths/yr National 26000 8000000 87 26769 6 6 14 4388 Dissemination Challenge •Available to anyone 50 years of age or older with a history of smoking or second hand smoke exposure •$199 for an individual, •$299 for a couple “The findings were INDISPUTABLE, “low dose” Lung CT saves lives by 20%.” •Available to: “Patients…age 40 and over, typically with a history of smoking of at least 100 cigarettes in a lifetime.” •$399 http://www.sequoiahospital.org/Medical_Services/Cancer_Care_and_Early_ Detection/SDR2_M177128 Thank you